FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

MC Morel-Kopp

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Procedures

Concepts & Ideas

Living Beings

Physiology

Geographic Areas

France

Co-author Network

Publications

TOP 3
L Halle; H Bach K; Corinne Martageix; Frederic Bianchi; T Lê T Kim; MC Morel-Kopp; J Soulier; C Tetaria; Cécile Kaplan
Eleven human platelet systems studied in the Vietnamese and Ma'ohis Polynesian populations.
MC Morel-Kopp; Chantal Melchior; P Chen; W Ammerlaan; Thomas Lecompte; Cécile Kaplan; NELLY KIEFFER
A naturally occurring point mutation in the beta3 integrin MIDAS-like domain affects differently alphavbeta3 and alphaIIIbbeta3 receptor function.
Sébastien Plançon; MC Morel-Kopp; Elisabeth Schaffner-Reckinger; P Chen; NELLY KIEFFER
Green fluorescent protein (GFP) tagged to the cytoplasmic tail of alphaIIb or beta3 allows the expression of a fully functional integrin alphaIIb(beta3): effect of beta3GFP on alphaIIb(beta3) ligand binding.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of MC Morel-Kopp (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: L Halle; H Bach K; Corinne Martageix; Frederic Bianchi; T Lê T Kim; MC Morel-Kopp; J Soulier; C Tetaria; Cécile Kaplan
Eleven human platelet systems studied in the Vietnamese and Ma'ohis Polynesian populations.
Tissue antigens 2004;63(1):34-40.
2001: MC Morel-Kopp; Chantal Melchior; P Chen; W Ammerlaan; Thomas Lecompte; Cécile Kaplan; NELLY KIEFFER
A naturally occurring point mutation in the beta3 integrin MIDAS-like domain affects differently alphavbeta3 and alphaIIIbbeta3 receptor function.
Thrombosis and haemostasis 2001;86(6):1425-34.
2001: Sébastien Plançon; MC Morel-Kopp; Elisabeth Schaffner-Reckinger; P Chen; NELLY KIEFFER
Green fluorescent protein (GFP) tagged to the cytoplasmic tail of alphaIIb or beta3 allows the expression of a fully functional integrin alphaIIb(beta3): effect of beta3GFP on alphaIIb(beta3) ligand binding.
The Biochemical journal 2001;357(Pt 2):529-36.
1997: MC Morel-Kopp; Cécile Kaplan; VALERIE PROULLE; Vincent Jallu; Chantal Melchior; Olivier Peyruchaud; M H Aurousseau; NELLY KIEFFER
A three amino acid deletion in glycoprotein IIIa is responsible for type I Glanzmann's thrombasthenia: importance of residues Ile325Pro326Gly327 for beta3 integrin subunit association.
Blood 1997;90(2):669-77.
1997: Olivier Peyruchaud; François Bourre; MC Morel-Kopp; D Reviron; P Mercier; Alan Nurden; Cécile Kaplan
HPA-10w(b) (La(a)): genetic determination of a new platelet-specific alloantigen on glycoprotein IIIa and its expression in COS-7 cells.
Blood 1997;89(7):2422-8.
1995: N Schlegel; O Gayet; MC Morel-Kopp; B Wyler; M F Hurtaud-Roux; Cécile Kaplan; J Mc Gregor
The molecular genetic basis of Glanzmann's thrombasthenia in a gypsy population in France: identification of a new mutation on the alpha IIb gene.
Blood 1995;86(3):977-82.
1995: MC Morel-Kopp; S Clemenceau; N Schlegel; T Lecompte; M H Aurousseau; Cécile Kaplan
Platelet phenotyping in carriers for Glanzmann's thrombasthenia: a simple screening test for assessment of the molecular defect.
Transfusion medicine (Oxford, England) 1995;5(2):123-9.
1994: Cécile Kaplan; MC Morel-Kopp; F Forestier; M Dreyfus; F Daffos; G Tchernia
[Fetal-neonatal thrombocytopenia of immunologic origin: current aspects].
Pathologie-biologie 1994;42(8):783-9.
1994: MC Morel-Kopp; S Clemenceau; M H Aurousseau; N Schlegel; Cécile Kaplan
Human platelet alloantigen typing: PCR analysis is not a substitute for serological methods.
Transfusion medicine (Oxford, England) 1994;4(1):9-14.
1992: Cécile Kaplan; MC Morel-Kopp; S Clemenceau; F Daffos; F Forestier; G Tchernia
Fetal and neonatal alloimmune thrombocytopenia: current trends in diagnosis and therapy.
Transfusion medicine (Oxford, England) 1992;2(4):265-71.
1992: Denis Reviron; P Mercier; C Dabanian; S Cambiaggi; M André; Y Delord; Cécile Kaplan; MC Morel-Kopp; Pascal Auquier
[Platelet group polymorphism in Provence. Comparison with the frequencies of platelet-specific allo-antigens observed in other populations].
Revue française de transfusion et d'hémobiologie : bulletin de la Société nationale de transfusion sanguine 1992;35(1):25-32.
1991: Cécile Kaplan; MC Morel-Kopp; H Kroll; V Kiefel; N Schlegel; N Chesnel; C Mueller-Eckhardt
HPA-5b (Br(a)) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases.
British journal of haematology 1991;78(3):425-9.